7NJZ image
Deposition Date 2021-02-17
Release Date 2021-07-21
Last Version Date 2024-11-13
Entry Detail
PDB ID:
7NJZ
Keywords:
Title:
X-ray crystallography study of RoAb13 which binds to PIYDIN, a part of the CCR5 N terminal domain
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
3.20 Å
R-Value Free:
0.29
R-Value Work:
0.26
R-Value Observed:
0.27
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Region from C-C chemokine receptor type 5 N-terminal domain
Gene (Uniprot):CCR5
Chain IDs:C
Chain Length:6
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Antibody RoAb13 Heavy Chain
Chain IDs:A (auth: H)
Chain Length:224
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Antibody RoAb13 Light Chain
Chain IDs:B (auth: L)
Chain Length:220
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
X-ray crystallographic studies of RoAb13 bound to PIYDIN, a part of the N-terminal domain of C-C chemokine receptor 5.
Iucrj 8 678 683 (2021)
PMID: 34258015 DOI: 10.1107/S2052252521005340

Abstact

C-C chemokine receptor 5 (CCR5) is a major co-receptor molecule used by HIV-1 to enter cells. This led to the hypothesis that stimulating an antibody response would block HIV with minimal toxicity. Here, X-ray crystallographic studies of the anti-CCR5 antibody RoAb13 together with two peptides were undertaken: one peptide is a 31-residue peptide containing the PIYDIN sequence and the other is the PIDYIN peptide alone, where PIYDIN is part of the N-terminal region of CCR5 previously shown to be important for HIV entry. In the presence of the longer peptide (the complete N-terminal domain), difference electron density was observed at a site within a hypervariable CDR3 binding region. In the presence of the shorter core peptide PIYDIN, difference electron density is again observed at this CDR3 site, confirming consistent binding for both peptides. This may be useful in the design of a new biomimetic to stimulate an antibody response to CCR5 in order to block HIV infection.

Legend

Protein

Chemical

Disease

Primary Citation of related structures